Navigation Links
New Microarray Labeling Kit for Preparing cDNA Probes


A more reliable and reproducible way to create fluorescently or radioactively labeled cDNA

David T. Wong Heidi Davis Darryl Garrison Terry Payette Matt Lundy
Kim Kuplent Mary A. Buchanan Joseph A. Sorge Rebecca L. Mullinax
Stratagene

Travis Ward Andrew Firmin
Phenogenex

Nucleic acid microrrays, which contain hundreds or thousands of genes in a single format, are increasingly being used to identify differentially expressed genes. In this process, test and control mRNA are converted into cDNA probes in a reverse transcription reaction that incorporates labeled nucleotides. The test and control cDNA probes are then hybridized to arrays, the unhybridized probe is removed, and the hybridization is detected. Differences in the levels of hybridization signals of specific genes on the array correlate with differences in the abundance of those genes in the test and control mRNA used to prepare the probes.

We have developed the Microarray Labeling KitPP for use with gene microarrays1 to increase the reliability and reproducibility of identifying differentially expressed genes. The kit includes several control mRNA and two Control Microarrays designed to assess the mRNA quality and the sensitivity and specificity of the assay.

Arabidopsis Control mRNA

The Microarray Labeling Kit includes three artificially generated mRNA from Arabidopsis thaliana genes. They are A. thaliana RUBISCO activase (rca), chlorophyll a/b-binding protein, and ribulose-1,5-biphosphate carboxylase/oxygenase large subunit (rbcL) genes. These genes were selected because they are involved in plant-specific processes and do not have known human homologues. In addition, they do not hybridize to membrane-arrayed human cDNA from 29 different tissues. Therefore, cDNA probes generated from these genes are unlikely to hybridize to human genes.

The three A. thaliana mRNA are added to the probe-labeling reaction at three different concentrations, along with test or control mRNA and labeled nucleotides provided by the researcher, to generate fluorescently cDNA probes. The probes are then hybridized to the Control Microarray to determine the effectiveness of the probe labeling and the specificity and sensitivity of the hybridization reactions.

Target DNA on Control Microarray

The Control Microarray is designed to assess mRNA quality to enable researchers to identify problems associated with poor quality mRNA before hybridizing the cDNA probe to an expensive microarray. The Control Microarray contains positive-control target DNA, a negative control, and additional human target DNA (Figure 1). The positive-control target DNA on the Control Microarray are A. thaliana RUBISCO activase (rca), chlorophyll a/b-binding protein, ribulose-1,5-biphosphate carboxylase/oxygenase large subunit (rbcL) genes, and the human -actin gene. Two samples containing only 3X SSC are provided as negative controls.

The Control Microarray also contains six additional human target DNA. These target DNA are expressed in different tissues at varying abundances and provide additional information regarding the quality of the labeled cDNA probe and efficiency of the hybridization.

Specificity and Sensitivity of the Assay

The A. thaliana control mRNA and target DNA on the Control Microarray can be used to determine the sensitivity of the assay. The A. thaliana-labeled probe is generated by adding the A. thaliana mRNA provided in the probe-labeling kit to the probe-labeling reaction. The amounts of A. thaliana photosystem I chlorophyll a/b-binding protein, rca and rbcL mRNA added to the probe-labeling reaction correspond to mRNA of high, medium, and low abundances, respectively. The relative fluorescent intensities of the A. thaliana cDNA probes when hybridized to the corresponding A. thaliana target DNA on the Control Microarray can therefore be used to determine the sensitivity of the assay (Figure 1).

Fig.1

The 3X SSC negative controls can be used to determine the specificity of the assay because the labeled probe should not hybridize to the spotted 3X SSC.

RNA Quality

The quality of the RNA is critical to successful probe preparation. The presence of contaminants, such as carbohydrates, can increase background fluorescence following hybridization. The guanidinium isothiocyanate method used in the StrataPrep total RNA miniprep kit2 has been used successfully in this application.

The human -actin and additional target gene-labeled probes are generated from the researchers test or control mRNA in the probe-labeling reaction. The abundances of these mRNA will vary with each tissue. The fluorescent intensities of the -actin and other human gene cDNA probes when hybridized to the corresponding target DNA on the Control Microarray can therefore be used to determine the quality of the researchers mRNA.

Conclusions

Use Stratagenes Microarray Labeling Kit to prepare reliable cDNA probes for hybridization to gene microarrays. The Arabidopsis control mRNA and Control Microarray included in the kit allow problems associated with poor-quality mRNA to be identified prior to hybridizing the probe to an expensive microarray and to determine the sensitivity and specificity of the hybridization.

REFERENCES

  1. Schena, M., et al. (1995) Science 270: 467-470.

  2. Dolter, K., et al. (2000) Strategies 13: 12-14.


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
2. An Optimal DNA Microarray Substrate for the Identification of Fetal and Somatic Liver Stem Cells of the Rat
3. Amplification of Mouse cDNAs for Microarrays Using the Eppendorf MasterTaq Kit
4. Microarray Target Purification Kit and the Microarray Target Synthesis Kit (T7)
5. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
6. Increased Sensitivity in Microarray Analysis
7. Analysis of Microarray Data
8. Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform
9. Is RNA Amplification Necessary for Microarrays?
10. Perform Microarray Analysis with Limited Bacterial RNA
11. Isolate High Quality Total RNA from LCM Samples Suitable for Microarray and qRT-PCR Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Microarray Labeling Kit for Preparing cDNA Probes

(Date:1/15/2014)... MINNEAPOLIS , Jan. 15, 2014 ­ RedBrick ... and behavior change technology, today announces that EmblemHealth ... insurer and wellness company, is now providing the RedBrick ... digital coaching program, to all of its members. EmblemHealth ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... As pet owners drew up their lists of New Year,s ... better care of my furry companion." Nowadays there are pet salons, ... cases to take the little canine or feline darlings along wherever ... buy some pricey toys at the pet store. But anyone who ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing ... two definitive license agreements with University Health Network (UHN) and ... , granting Trillium exclusive worldwide rights to commercialize two immunology ... cancer. , ...
... of animals and plants is the most important technological ... species has occurred as humans have used individuals carrying ... issue of Nature an international team led ... the secrets underlying the remarkable development of the domestic ...
... ... ... , ... , , , , ...
Cached Biology Technology:Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 2Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 3Scientific breakthrough in genetic studies of animal domestication 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 3
(Date:7/10/2014)... yellow crazy ant Anoplolepis gracilipes is ranked amongst ... for catastrophic ecological impacts on islands. A new study published ... examines and assesses the effects and dangers of the introduction ... the mature palm forest of the Valle de Mai, a ... forest of Valle de Mai is a unique ecosystem containing ...
(Date:7/10/2014)... the West African nation Burkina Faso today have ... Press has the potential to increase access to ... and in communities by combining a lower-dose formulation ... acetate)with the BD Uniject injection system. , Burkina ... expected to begin introducing Sayana Press in 2014, ...
(Date:7/9/2014)... pivotal in the development of cancer, viral infection and ... question about one of the most widely-researched proteins in ... of thousands of research papers and millions of pounds ... in Professor Sir Philip Cohen,s laboratory at the University ... is activated. The results are published today ...
Breaking Biology News(10 mins):Invasion of yellow crazy ant in a Seychelles UNESCO palm forest: Threats and solutions 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3Research reveals how key controller protein is switched on 2
... Santa Barbara, Calif. UC Santa Barbara resource economists ... effects of a fisheries management system implemented by the National ... is funded as part of a $1 million West Coast ... and its partners. The "catch shares" program was created ...
... Md. -- Each year the American Society of Plant ... investigators through a competitive process to attend the Plant ... Young Investigator Travel Award (WYITA) program is to increase ... as an independent scientist in academia, industry, or government ...
... Childrens Research Institute and the University of Melbourne have ... allergy. It is hoped the test would be ... minimise over-diagnosis of peanut allergy in the community. ... standard for diagnosing peanut allergy, and while an oral ...
Cached Biology News:UCSB researchers to examine the effects of year-old NOAA West Coast 'Catch Shares' program 2American Society of Plant Biologists honors early career women scientists 2Test to improve peanut allergy diagnosis 2
...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Goat polyclonal to HNF4 ( Abpromise for all tested applications). Antigen: Synthetic peptide: RLSKTLVDMDMADY (Human) N terminal. Entrez GeneID: 3172 Swiss Protein ID: P41235...
Biology Products: